EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

PACAP ‐38 in Cluster Headache: A Prospective, Case–Control Study of a Potential Treatment Target

Marie-Louise K Søborg iD, Nunu Lund, Agneta Snoer, Mads Barloese, Rigmor Højland Jensen, Anja Sofie Petersen iD

European Journal of Neurology · 2025

DOI: 10.1111/ene.70341 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Marie-Louise K Søborg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Danish Headache Center, Department of Neurology, University of Copenhagen, Rigshospitalet-Glostrup, Glostrup, Denmark. Hauptthemen laut MEDLINE: Cluster Headache, Pituitary Adenylate Cyclase-Activating Polypeptide. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: H. Lundbeck A/S, Region Hovedstaden, Rigshospitalet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Estimates of pituitary adenylate cyclase‐activating peptide‐38's (PACAP‐38) activity in cluster headache are sparse. We investigated whether plasma levels of PACAP‐38 differ between disease states (i.e., bout, remission, chronic) and compared to headache‐free controls. Secondly, we assessed a possible correlation between plasma levels of PACAP‐38 and Calcitonin gene‐related peptide (CGRP).

Methods

In an observational case–control setup, prospectively collected interictal plasma samples from participants in the Danish Cluster Headache Biobank were analyzed for plasma levels of PACAP‐38 and CGRP. All participants had blood samples drawn; once if chronic cluster headache or controls, and twice if episodic cluster headache (in bout and in remission phase). Plasma levels were measured with validated immunoassays.

Results

Plasma was derived from 205 patients with cluster headache according to ICHD‐3 criteria and 101 sex‐ and age‐matched headache‐free controls. PACAP‐38 plasma levels were significantly higher in all three disease states of cluster headache: compared to controls, they collectively had a 34.3% (95% CI: 20%–49%, p < 0.0001) higher mean PACAP‐38 level. Chronic cluster headache showed the greatest difference by 49.8% (95% CI: 26.7–77.2, p < 0.0001) higher PACAP‐38 levels, while episodic cluster headache in bout and remission showed respectively 39.5% (95% CI: 18.8–63.8, p < 0.0001) and 34.1% (95% CI: 14.2–57.5, p = 0.0005) higher plasma levels. No correlation between plasma levels of PACAP‐38 and CGRP was demonstrated (Spearmans r = 0.08, p = 0.10).

Conclusions

This large‐scale study demonstrated increased PACAP‐38 levels in all disease states of cluster headache compared to headache‐free controls, strengthening the hope of a possible effect of PACAP‐38 targeting treatments in future trials. The lacking correlation between PACAP‐38 and CGRP levels should be interpreted with caution and needs to be investigated in future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cluster HeadachePituitary Adenylate Cyclase-Activating PolypeptideHumansMaleFemaleCase-Control StudiesMiddle AgedAdultCalcitonin Gene-Related PeptideProspective Studies

Stichwörter der Autor:innen

PACAP38cluster headachetreatment

Substanzen

Pituitary Adenylate Cyclase-Activating PolypeptideCalcitonin Gene-Related Peptide

Autor:innen und Institutionen

  • Danish Headache Center, Department of Neurology, University of Copenhagen, Rigshospitalet-Glostrup, Glostrup, Denmark.
  • Centre for Functional and Diagnostic Imaging and Research, Hvidovre Hospital, Hvidovre, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Marie-Louise K Søborg, Anja Sofie Petersen

Förderung

  • H. Lundbeck A/S
  • Region Hovedstaden
  • Rigshospitalet

Zitieren

APA

Søborg, M. K., Lund, N., Snoer, A., Barloese, M., Jensen, R. H., & Petersen, A. S. (2025). PACAP ‐38 in Cluster Headache: A Prospective, Case–Control Study of a Potential Treatment Target. European Journal of Neurology. https://doi.org/10.1111/ene.70341

Vancouver

Søborg MK, Lund N, Snoer A, Barloese M, Jensen RH, Petersen AS. PACAP ‐38 in Cluster Headache: A Prospective, Case–Control Study of a Potential Treatment Target. European Journal of Neurology. 2025. doi:10.1111/ene.70341

BibTeX
@article{Sborg2025,
  author = {Søborg, Marie-Louise K and Lund, Nunu and Snoer, Agneta and Barloese, Mads and Jensen, Rigmor Højland and Petersen, Anja Sofie},
  title = {PACAP ‐38 in Cluster Headache: A Prospective, Case–Control Study of a Potential Treatment Target},
  journal = {European Journal of Neurology},
  year = {2025},
  doi = {10.1111/ene.70341}
}
Kostenlos starten →